PCVX News and Press, Vaxcyte Inc. From 11/04/25

Final Data from VAX-24 Infant Phase 2 Dose-Finding Study Consistent with Previously Reported Positive Interim Data; Provide Additional Evidence Supporting Higher VAX-31 Doses Being Evaluated in Ongoing Infant Phase 2 Study Modified VAX-31 Infant Phase 2 Dose-Finding Study Advanced to ...

Advanced Energy Industries Inc. (AEIS) is expected to report $1.16 for Q3 2025 Neuropace Inc. (NPCE) is expected to report $-0.2 for Q3 2025 Oportun Financial Corporation (OPRT) is expected to report $0.2 for Q3 2025 trivago N.V. (TRVG) is expected to report $0.07 for Q3 2025 Alle...

Vaxcyte Inc. (PCVX) is expected to report $-1.27 for Q3 2025

2025-11-03 17:42:28 ET Vaxcyte, Inc. (PCVX) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 2.08%. The average open to low on the day of earnings was -4.30%. The average open to close on...

2025-11-03 17:37:29 ET Vaxcyte, Inc. (PCVX) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in PCVX stock price following earnings has averaged ±2.36% , with a median of 2.11%. The si...

2025-10-13 11:15:14 ET More on related tickers Kratos Defense: High Hopes In Unmanned Tech, But Valuation Clouds Near-Term Upside CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic? Oscar Health: What The U.S. Government Shutdown Means To The Company ...

2025-09-30 09:03:48 ET More on Vaxcyte, Thermo Fisher Scientific Thermo Fisher: A Wide-Moat Leader With Multi-Year Growth Ahead Thermo Fisher: A Hold For Stability, Not For Outperformance Vaxcyte, Inc. (PCVX) Presents At Cantor Global Healthcare Conference 2025 Trans...

New Agreement with Thermo Fisher Scientific Expands Domestic Capacity to Support Future Commercial Manufacturing of Vaxcyte’s Broad-Spectrum Pneumococcal Conjugate Vaccine Candidates SAN CARLOS, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinica...

2025-09-07 22:01:08 ET Vaxcyte, Inc. (PCVX) Cantor Global Healthcare Conference 2025 September 3, 2025 2:45 PM EDT... Read the full article on Seeking Alpha For further details see: Vaxcyte, Inc. (PCVX) Presents At Cantor Global Healthcare Conference 2025 Transcript

2025-06-12 10:10:00 ET PERFORMANCE RECAP The S&P 1500 Health Care Index (the Index) gained 0.9% in February, outperforming the S&P 500, which declined -1.3%. Biotechnology, health care technology, and pharmaceuticals outperformed the Index during the...